A novel missense variant in TXNDC3 is associated with developmental dysplasia of the hip in Han Chinese population.

Developmental dysplasia of the hip (DDH) is one of the most common inborn disabilities of the hip joint and a common disease with a genetic component for its etiology. However, genetic basis of Developmental dysplasia of the hip (DDH) remains largely unknown. Previous study has identified that TXNDC3 is significant associated with osteoarthritis and the development of chondrocytes and bone. In this study, we carried out a case-control study to investigate for the association between TXNDC3 and DDH, to find whether acetabular cartilage and bone formation in hip developmental progress is regulated by TXNDC3. We totally enrolled 984 radiology confirmed DDH children and 2043 healthy controls to conduct a case-control association study by genotyping SNP rs10250905 on TXNDC3. The rs10250905 variant is further detected in 7 DDH pedigrees which comprise total 15 familial DDH patients. The SNP was significantly associated with DDH, P = 1.53*10-5 with the odds ratio of 0.786 (0.705-0.877) for allele T; P = 0.0075 with the odds ratio of 0.761 (0.622-0.930) for genotype TT. Furthermore, the significant difference was also detected in samples when stratified by gender. In case-control study, the allele T frequency in cases (0.397) was lower than in controls (0.456). In addition, the allele T frequency in cases of DDH families was 0.300 and in controls was 0.433. In conclusion, our study demonstrates a novel missense variant of TXNDC3, rs10250905, is strongly associated with DDH in Han Chinese population and it shows protective allele T.

[1]  D. Duggan,et al.  Association Analysis of BMD‐associated SNPs with Knee Osteoarthritis , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  R. Aitken,et al.  Functional deletion of Txndc2 and Txndc3 increases the susceptibility of spermatozoa to age-related oxidative stress. , 2013, Free radical biology & medicine.

[3]  Daniel L. Koller,et al.  Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture , 2012, Nature Genetics.

[4]  D. Shi,et al.  Association of the D repeat polymorphism in the ASPN gene with developmental dysplasia of the hip: a case-control study in Han Chinese , 2011, Arthritis Research & Therapy.

[5]  D. Shi,et al.  Association of a single nucleotide polymorphism in Tbx4 with developmental dysplasia of the hip: a case-control study. , 2010, Osteoarthritis and cartilage.

[6]  D. Shi,et al.  Association of a single nucleotide polymorphism in growth differentiate factor 5 with congenital dysplasia of the hip: a case-control study , 2008, Arthritis research & therapy.

[7]  S. Rishpon,et al.  Developmental dysplasia of the hip: Risk markers, clinical screening and outcome , 2008, Pediatrics international : official journal of the Japan Pediatric Society.

[8]  D. Shi,et al.  Association of single-nucleotide polymorphisms in RHOB and TXNDC3 with knee osteoarthritis susceptibility: two case-control studies in East Asian populations and a meta-analysis , 2008, Arthritis research & therapy.

[9]  S. Amselem,et al.  A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia , 2007, Proceedings of the National Academy of Sciences.

[10]  Hans-Jürgen Thiesen,et al.  Cis- and trans-acting gene regulation is associated with osteoarthritis. , 2006, American journal of human genetics.

[11]  S. Jacobsen,et al.  Hip dysplasia: a significant risk factor for the development of hip osteoarthritis. A cross-sectional survey. , 2005, Rheumatology.

[12]  Y. P. Low,et al.  Significance of the lateral epiphysis of the acetabulum to hip joint stability. , 2000, Journal of pediatric orthopedics.

[13]  M. Goossens,et al.  Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. , 1998, The Journal of clinical investigation.

[14]  E. Haan,et al.  Perinatal risk factors for developmental dysplasia of the hip , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[15]  P. Beighton,et al.  Beukes familial hip dysplasia: an autosomal dominant entity. , 1990, American journal of medical genetics.

[16]  S. Weinstein Natural history of congenital hip dislocation (CDH) and hip dysplasia. , 1987, Clinical orthopaedics and related research.

[17]  P. Harper,et al.  Report of the delegation of clinical geneticists to China, Spring 1986. , 1987, Biology and society : the journal of the Eugenics Society.

[18]  G. Tusnády,et al.  Two family studies on congenital dislocation of the hip after early orthopaedic screening Hungary. , 1975, Journal of medical genetics.

[19]  M. Geiser,et al.  Congenital dislocation of the hip in identical twins. , 1959, The Journal of bone and joint surgery. British volume.

[20]  Qun Zhao,et al.  Association of a single nucleotide polymorphism in pregnancy-associated plasma protein-A2 with developmental dysplasia of the hip: a case-control study. , 2012, Osteoarthritis and cartilage.

[21]  R. Patel-King,et al.  Redox-based control of the gamma heavy chain ATPase from Chlamydomonas outer arm dynein. , 2002, Cell motility and the cytoskeleton.

[22]  C. Scapoli,et al.  A two-locus model for non-syndromic congenital dysplasia of the hip (CDH). , 2000 .

[23]  W. Nance,et al.  Familial aggregation of congenital dislocation of the hip in a Norwegian population. , 1988, Journal of clinical epidemiology.